Literature DB >> 21196186

Growth Factors and their receptors in cancer metastases.

Shi Yu Yang1, Anur Miah, Amit Pabari, Marc Winslet.   

Abstract

Metastatic, rather than primary tumours are responsible for ninety percent cancer deaths. Despite significant advances in the understanding of molecular and cellular mechanisms in tumour metastases, there are limitations in preventive treatment of metastatic tumours. Much evidence arising from laboratory and clinical studies suggests that growth factors and their receptors are implicated in cancer metastases development. We review the origin and production of growth factors and their receptors in all stages of cancer metastases including epithelial-mesenchymal transition, cancer cell invasion and migration, survival within the circulation, seeding at distant organs and metastatic tumour angiogenesis. The functions of growth factors and their receptors are also discussed. This review presents the efforts made in understanding this challenge to aid in the development of new treatment strategies for cancer metastases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196186     DOI: 10.2741/3703

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  16 in total

1.  The igf system in carcinogenesis and its implication for cancer therapy.

Authors:  S Y Yang; M Winslet
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

2.  Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity.

Authors:  Melinda Halasz; Beata Polgar; Gergely Berta; Livia Czimbalek; Julia Szekeres-Bartho
Journal:  Cell Mol Life Sci       Date:  2013-06-27       Impact factor: 9.261

3.  Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.

Authors:  Mine Erguven; Ayhan Bilir; Nuray Yazihan; Seval Korkmaz; Esin Aktas; Cem Ovalioglu; Tolga Dundar; Hakan Seyithanoglu
Journal:  Oncol Lett       Date:  2011-10-04       Impact factor: 2.967

4.  Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.

Authors:  Lei Jin; Yan Zhang; Hui Li; Ling Yao; Da Fu; Xuebiao Yao; Lisa X Xu; Xiaofang Hu; Guohong Hu
Journal:  Cell Res       Date:  2012-06-12       Impact factor: 25.617

Review 5.  Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis.

Authors:  Meysam Yousefi; Rahim Nosrati; Arash Salmaninejad; Sadegh Dehghani; Alireza Shahryari; Alihossein Saberi
Journal:  Cell Oncol (Dordr)       Date:  2018-03-22       Impact factor: 6.730

6.  Expression of transforming growth factor-β1 (TGF-β1) and E-cadherin in glioma.

Authors:  Liu Yang; Mei Liu; Chuanzong Deng; Zhikai Gu; Yilu Gao
Journal:  Tumour Biol       Date:  2012-04-29

Review 7.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

Review 8.  Epigenetic control of epithelial-mesenchymal-transition in human cancer.

Authors:  Tobias Kiesslich; Martin Pichler; Daniel Neureiter
Journal:  Mol Clin Oncol       Date:  2012-09-25

9.  STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma.

Authors:  Jennifer Hardee; Zhengqing Ouyang; Yuping Zhang; Anshul Kundaje; Philippe Lacroute; Michael Snyder
Journal:  G3 (Bethesda)       Date:  2013-12-09       Impact factor: 3.154

10.  A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity.

Authors:  R Castoldi; V Ecker; L Wiehle; M Majety; R Busl-Schuller; M Asmussen; A Nopora; U Jucknischke; F Osl; S Kobold; W Scheuer; M Venturi; C Klein; G Niederfellner; C Sustmann
Journal:  Oncogene       Date:  2013-07-01       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.